Eurocondor Consortium Starts Clinical trial for Diabetic Retinopathy

A clinical trial to evaluate a new therapeutic treatment using eye drops for the early stages of diabetic retinopathy started this week, researchers announced. A group of leading European ophthalmologists, endocrinologists and researchers have gathered together with BCN Peptides (a biopharmaceutical SME) under EUROCONDOR, the European Consortium on the early treatment of diabetic retinopathy, and will conduct the clinical trial in 11 clinical centres across the EU. Press release EUROCONDOR